Cheng Chen

2.3k total citations · 1 hit paper
98 papers, 1.6k citations indexed

About

Cheng Chen is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cheng Chen has authored 98 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 27 papers in Epidemiology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cheng Chen's work include Tuberculosis Research and Epidemiology (14 papers), Cancer Immunotherapy and Biomarkers (10 papers) and COVID-19 Clinical Research Studies (10 papers). Cheng Chen is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Cancer Immunotherapy and Biomarkers (10 papers) and COVID-19 Clinical Research Studies (10 papers). Cheng Chen collaborates with scholars based in China, United States and Singapore. Cheng Chen's co-authors include Xueguang Zhang, Jian‐An Huang, Chuanyong Mu, Ying Chen, Qiu‐Xia Qu, Yu Shen, Yibei Zhu, Guilin Ma, Linkun Hu and Xuqin Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.

In The Last Decade

Cheng Chen

89 papers receiving 1.5k citations

Hit Papers

High expression of PD-L1 in lung cancer may contribute to... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Chen China 17 730 421 316 314 206 98 1.6k
Joo Seop Chung South Korea 23 515 0.7× 394 0.9× 116 0.4× 249 0.8× 116 0.6× 101 1.8k
Steven H. Kroft United States 29 775 1.1× 589 1.4× 86 0.3× 204 0.6× 180 0.9× 119 2.9k
Hans Schlößer Germany 21 1.3k 1.8× 924 2.2× 352 1.1× 280 0.9× 154 0.7× 65 2.6k
K. Gutensohn Germany 23 329 0.5× 232 0.6× 137 0.4× 168 0.5× 224 1.1× 90 1.7k
Hongxiang Wang China 24 613 0.8× 330 0.8× 362 1.1× 379 1.2× 192 0.9× 86 2.8k
Dong Guo China 19 368 0.5× 97 0.2× 115 0.4× 183 0.6× 182 0.9× 63 1.0k
Hongbo Wang China 22 301 0.4× 197 0.5× 283 0.9× 210 0.7× 199 1.0× 99 1.8k
Kichul Shin South Korea 25 187 0.3× 903 2.1× 135 0.4× 223 0.7× 416 2.0× 126 2.5k
Zhanguo Zhang China 22 426 0.6× 132 0.3× 431 1.4× 182 0.6× 174 0.8× 76 2.0k

Countries citing papers authored by Cheng Chen

Since Specialization
Citations

This map shows the geographic impact of Cheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Chen more than expected).

Fields of papers citing papers by Cheng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Chen. The network helps show where Cheng Chen may publish in the future.

Co-authorship network of co-authors of Cheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Chen. A scholar is included among the top collaborators of Cheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Chen. Cheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Dong, Yang Wang, Shiying Guo, et al.. (2025). Lung puncture biopsies based targeted NGS increase clinical benefit to patients with short-term progressive pulmonary lesions suspected to be benign. International Journal of Infectious Diseases. 162. 108232–108232.
2.
Zhang, Yaoxin, et al.. (2025). High CD38 expression defines a mitochondrial function-adapted CD8+ T cell subset with implications for lung cancer immunotherapy. Cancer Immunology Immunotherapy. 74(2). 49–49. 3 indexed citations
3.
Jiang, Wei, Yong Yao, & Cheng Chen. (2025). Oxymatrine reduces neuropathic pain in diabetic mice through the p38 MAPK/NF-κB signaling pathway.. PubMed. 38(1). 89–100.
4.
Liu, Shuang, Guannan Shu, Minyu Chen, et al.. (2025). STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis. Cell Death and Disease. 16(1). 125–125. 4 indexed citations
5.
Wang, Sheng, et al.. (2025). The influence of PPARγ mediated MAPK and NF-κB activation in AGEs stimulated apoptosis and autophagy in human chondrocytes. Journal of Orthopaedics. 66. 204–212. 1 indexed citations
6.
Ning, Weiwei, et al.. (2024). Additional EBUS-guided intralesional amphotericin B injection combined systemic intravenous therapy in pulmonary mucormycosis: a case report. Therapeutic Advances in Respiratory Disease. 18. 2693846570–2693846570. 1 indexed citations
7.
Wu, Shi‐Nan, Jinyu Hu, Cheng Chen, et al.. (2024). Prediction model for ocular metastasis of breast cancer: machine learning model development and interpretation study. BMC Cancer. 24(1). 1472–1472.
8.
Zhou, Danhong, Yang Wang, Weiwei Ning, & Cheng Chen. (2023). Comparison of primary and metastatic site‐related PD‐L1 expression in predicting ORR in patients with advanced NSCLC who received ICB‐based therapy. Thoracic Cancer. 15(5). 379–385. 1 indexed citations
9.
Chen, Cheng, Lulu Gao, Hongwei Ge, et al.. (2023). A neural network model was constructed by screening the potential biomarkers of aortic dissection based on genes associated with pyroptosis. Aging. 15(21). 12388–12399. 1 indexed citations
10.
Lin, Yao, Tao Zou, Yanjun Feng, et al.. (2022). Comparison of initial clinic characteristics of hospitalized patients in Suzhou City during the COVID-19 Omicron wave with ancestral variant wave. Therapeutic Advances in Respiratory Disease. 16. 2673689674–2673689674. 4 indexed citations
11.
Jin, Yujia, et al.. (2022). Risk Factors and Impact on Outcomes of Lung Cancer Patients Concurrent with Deep Vein Thrombosis. Cancer Control. 29. 2905563122–2905563122. 7 indexed citations
12.
Jin, Yujia, et al.. (2022). Intermediate risk pulmonary embolism concomitant with or without lung cancer: a wide spectrum of features. Clinical and Experimental Hypertension. 44(7). 589–594.
13.
Chen, Cheng, et al.. (2021). Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters. BMC Medical Imaging. 21(1). 150–150. 13 indexed citations
14.
Yu, Kun, et al.. (2020). Effects of processing techniques on the quality properties and lipid concomitants of flaxseed oil.. Shipin Kexue / Food Science. 41(16). 233–243. 3 indexed citations
15.
Zhou, Yang, Cheng Chen, Hui Jiang, et al.. (2019). High admission rates and heavy inpatient service costs of urban tuberculosis patients in eastern China. BMC Health Services Research. 19(1). 7 indexed citations
16.
Liu, Qiao, Guoli Li, Cheng Chen, et al.. (2017). Diagnostic Performance of the GenoType MTBDRplus and MTBDRsl Assays to Identify Tuberculosis Drug Resistance in Eastern China. Chinese Medical Journal. 130(13). 1521–1528. 10 indexed citations
17.
Shen, Xu-Rui, et al.. (2015). Feasibility study of fractional exhaled nitric oxide in the dignosis of cough variant asthma. Chinese Journal of Asthma. 35(5). 329–332. 1 indexed citations
18.
Yang, Huilan, et al.. (2014). [The diagnostic value of serum beta-hydroxybutyrate in diabetic ketosis or diabetic ketoacidosis].. PubMed. 45(2). 270–3. 2 indexed citations
19.
Lü, Wei, Cheng Chen, Yan Shao, et al.. (2012). Evaluation of Biochip System in Determining Isoniazid and Rifampicin Resistances of Mycobacterium Tuberculosis in Sputum Samples. PLoS ONE. 7(12). e52953–e52953. 4 indexed citations
20.
Xu, Qiongming, Lingchuan Guo, Xinhua Gu, et al.. (2012). Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12. Biomaterials. 33(15). 3909–3918. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026